Market closed
Pfizer/$PFE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Ticker
$PFE
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
81,000
Website
Pfizer Metrics
BasicAdvanced
$143B
17.86
$1.41
0.54
$1.69
6.82%
Price and volume
Market cap
$143B
Beta
0.54
52-week high
$31.54
52-week low
$24.48
Average daily volume
52M
Dividend rate
$1.69
Financial strength
Current ratio
1.171
Quick ratio
0.82
Long term debt to equity
67.898
Total debt to equity
73.408
Dividend payout ratio (TTM)
118.44%
Interest coverage (TTM)
5.28%
Management effectiveness
Return on assets (TTM)
4.64%
Return on equity (TTM)
8.85%
Valuation
Price to earnings (TTM)
17.855
Price to revenue (TTM)
2.244
Price to book
1.55
Price to tangible book (TTM)
-3.94
Price to free cash flow (TTM)
14.519
Dividend yield (TTM)
6.70%
Forward dividend yield
6.82%
Growth
Revenue change (TTM)
8.77%
Earnings per share change (TTM)
284.33%
3-year revenue growth (CAGR)
-7.84%
3-year earnings per share growth (CAGR)
-28.45%
3-year dividend per share growth (CAGR)
2.50%
What the Analysts think about Pfizer
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Pfizer stock.
Pfizer Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Pfizer Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Pfizer News
AllArticlesVideos
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views
Fast Company·3 hours ago
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
CNBC·7 hours ago
Biotech stocks tumble on reports FDA's top vaccine regulator to leave
Reuters·10 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Pfizer stock?
Pfizer (PFE) has a market cap of $143B as of March 31, 2025.
What is the P/E ratio for Pfizer stock?
The price to earnings (P/E) ratio for Pfizer (PFE) stock is 17.86 as of March 31, 2025.
Does Pfizer stock pay dividends?
Yes, the Pfizer (PFE) stock pays dividends to shareholders. As of March 31, 2025, the dividend rate is $1.69 and the yield is 6.82%. Pfizer has a payout ratio of 118.44% on a trailing twelve-month basis.
When is the next Pfizer dividend payment date?
The next Pfizer (PFE) dividend payment date is unconfirmed.
What is the beta indicator for Pfizer?
Pfizer (PFE) has a beta rating of 0.54. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.